Immutable evidence record · ticker
Liminatus Pharma, Inc. Class A Common Stock (LIMN)
Published as observed on 18 August 2026 at 22:04 BST.
Liminatus Pharma, Inc. Class A Common Stock has a balanced company news read. Its latest completed weekly trend is negative.
- As of
- 18 Aug 2026, 22:04
- Scope
- company and instrument
- Evidence
- 23 items
- Independent sources
- 1
- Country
- United States
- Sector
- Healthcare
- Previous read
- 50.000
- Change
- —
Verification
Evidence & related research
Company chart →Technicals & Market Dynamics →Technical Research Pack →Company news sentiment →Current financial news →
This is dated market research. Coverage may be delayed, incomplete or unavailable.
Cite this record:
Sharemaestro, Liminatus Pharma, Inc. Class A Common Stock (LIMN), 2026-08-18, https://sharemaestro.com/evidence/2a550427-2451-4d3e-aa36-4c39b2420485/
Record checksum 79f66238fbf1d175e429d3182933319d0f05166be3b8bb3319782051e1a53f6f
